{
    "id": "0027",
    "question": "A 26-year-old woman presents to a gynecologist after a missed period. After performing a complete physical examination and a screening test for pregnancy, her gynecologist informs her that she is pregnant. She is very surprised as she has been taking oral contraceptives regularly. When the gynecologist asks her about the consumption of any other medications, she mentions that she was placed on treatment for pulmonary tuberculosis (TB) 2 months ago. Her current anti-TB regimen includes rifampin, isoniazid, pyrazinamide, and ethambutol. Which of the following mechanisms best explains the failure of oral contraceptives in this patient?",
    "options": {
        "A": "Induction of CYP3A4 by rifampin leading to decreased serum levels of ethinylestradiol and progesterone",
        "B": "Induction of CYP2A6 by rifampin leading to increased inactivation of ethinylestradiol",
        "C": "Interference with the intestinal absorption of the oral contraceptive by pyrazinamide",
        "D": "Increased renal elimination of the progesterone component of the oral contraceptive by ethambutol"
    },
    "answer": "A",
    "predict": "To approach this question, let's break down the key points and analyze each option: 1. **Patient's situation**: The patient is a 26-year-old woman who is pregnant and taking oral contraceptives (OCs) that have failed, and she has been on treatment for pulmonary tuberculosis (TB) with rifampin, isoniazid, pyrazinamide, and ethambutol. 2. **Understanding the interaction**: The patient's failure of OCs can be attributed to one of the anti-TB medications. We need to identify which one is most likely responsible. 3. **Pharmacokinetics of oral contraceptives**: Oral contraceptives typically contain a combination of an estrogen (ethinylestradiol) and a progestin. The effectiveness of OCs depends on the stability and bioavailability of these components. 4. **Metabolism of ethinylestradiol**: Ethinylestradiol is primarily metabolized by the liver through the cytochrome P450 enzyme system, specifically CYP3A4. 5. **Effect of rifampin on CYP3A4**: Rifampin is a potent inducer of CYP3A4. Induction of CYP3A4 increases the metabolism of ethinylestradiol, leading to decreased serum levels and reduced effectiveness of the oral contraceptive. 6. **Analyzing the options**: - A. **Induction of CYP3A4 by rifampin leading to decreased serum levels of ethinylestradiol and progesterone**: This option is consistent with the known interaction between rifampin and CYP3A4, which would decrease the serum levels of ethinylestradiol and progesterone, leading to failure of oral contraceptives. - B. Induction of CYP2A6 by rifampin leading to increased inactivation of ethinylestradiol: While rifampin does induce CYP2A6, this is not the primary enzyme responsible for ethinylestradiol metabolism. - C. Interference with the intestinal absorption of the oral contraceptive by pyrazinamide: Pyrazinamide is not known to affect the absorption of oral contraceptives. - D. Increased renal elimination of the progesterone component of the oral contraceptive by ethambutol: Ethambutol is not known to affect the renal elimination of progestins. **Conclusion**: The most likely explanation for the failure of oral contraceptives in this patient is the induction of CYP3A4 by rifampin, leading to decreased serum levels of ethinylestradiol and progesterone. **Output in json format**: ``` {\"step_by_step_thinking\": \"The key to this question lies in understanding the interaction between rifampin and the cytochrome P450 enzyme system, specifically CYP3A4, which is responsible for the metabolism of ethinylestradiol in oral contraceptives. Rifampin is a potent inducer of CYP3A4, leading to decreased serum levels of ethinylestradiol and progesterone, and thus, the failure of oral contraceptives. The other options do not provide a plausible explanation for the observed interaction.\", \"answer_choice\": \"A\"} ```",
    "snippets": [],
    "scores": [],
    "execution_time": 44.532978773117065
}